-
Something wrong with this record ?
Current and Future Pathways in Aspergillus Diagnosis
R. Dobiáš, DA. Stevens, V. Havlíček
Status not-indexed Language English Country Switzerland
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
- Publication type
- Journal Article MeSH
- Review MeSH
Aspergillus fumigatus has been designated by the World Health Organization as a critical priority fungal pathogen. Some commercially available diagnostics for many forms of aspergillosis rely on fungal metabolites. These encompass intracellular molecules, cell wall components, and extracellular secretomes. This review summarizes the shortcomings of antibody tests compared to tests of fungal products in body fluids and highlights the application of β-d-glucan, galactomannan, and pentraxin 3 in bronchoalveolar lavage fluids. We also discuss the detection of nucleic acids and next-generation sequencing, along with newer studies on Aspergillus metallophores.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23002943
- 003
- CZ-PrNML
- 005
- 20230421100055.0
- 007
- ta
- 008
- 230413s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antibiotics12020385 $2 doi
- 035 __
- $a (PubMed)36830296
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Dobiáš, Radim $u Department of Bacteriology and Mycology, Public Health Institute in Ostrava, Partyzánské Náměstí 2633/7, 702 00 Ostrava, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000342999169 $7 xx0224073
- 245 10
- $a Current and Future Pathways in Aspergillus Diagnosis / $c R. Dobiáš, DA. Stevens, V. Havlíček
- 520 9_
- $a Aspergillus fumigatus has been designated by the World Health Organization as a critical priority fungal pathogen. Some commercially available diagnostics for many forms of aspergillosis rely on fungal metabolites. These encompass intracellular molecules, cell wall components, and extracellular secretomes. This review summarizes the shortcomings of antibody tests compared to tests of fungal products in body fluids and highlights the application of β-d-glucan, galactomannan, and pentraxin 3 in bronchoalveolar lavage fluids. We also discuss the detection of nucleic acids and next-generation sequencing, along with newer studies on Aspergillus metallophores.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Stevens, David A $u California Institute for Medical Research, 2260 Clove Drive, San Jose, CA 95128, USA $u Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 95128, USA
- 700 1_
- $a Havlíček, Vladimír $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic $u Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. Listopadu 12, 771 46 Olomouc, Czech Republic $1 https://orcid.org/0000000286147059 $7 jx20041110004
- 773 0_
- $w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 12, č. 2 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36830296 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20230421100047 $b ABA008
- 999 __
- $a ok $b bmc $g 1922719 $s 1189150
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 12 $c 2 $e 20230213 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
- LZP __
- $a Pubmed-20230413